keyword
https://read.qxmd.com/read/38838119/association-between-chronic-pancreatitis-and-pancreatic-cancer-at-a-central-hospital-in-kwazulu-natal-south-africa
#1
JOURNAL ARTICLE
F G Madela, M S A Sithole, N C Ntanzi, K S Chiliza, S Kader, A Mwazha, S R Thomson, C Aldous
BACKGROUND: The frequency of histological chronic pancreatitis (CP) evidence in the resident pancreas of resected periampullary cancers (PACs) has never been studied in Africa. This study aims to describe the spectrum of pathology and outcomes of pancreatic surgeries and address this deficit from a South African central hospital cohort. METHODS: A retrospective audit of patients undergoing pancreatic surgery at Inkosi Albert Luthuli Central Hospital (IALCH) between 2003 and 2023 was conducted...
May 2024: South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie
https://read.qxmd.com/read/38837874/genetic-and-immune-identification-and-functional-analysis-of-trpm8-as-a-potential-biomarker-for-pancreatic-adenocarcinoma-proliferation
#2
JOURNAL ARTICLE
Sen Qiao, Fengming Wu, Hongmei Wang
BACKGROUND: Pancreatic adenocarcinoma (PAAD), a member of highly lethal malignant tumors, has a poor outcome and extremely poor prognosis. The transient receptor potential (TRP) superfamily, a group of nonselective cation channels, is capable of influencing cellular functions by regulating calcium homeostasis. In addition, it has been shown that TRP channels can also affect various cellular phenotypes by regulating gene transcription levels and are involved in the development of a variety of malignant tumors...
June 2024: Cancer reports
https://read.qxmd.com/read/38837745/unlocking-clinical-insights-lymphocyte-specific-protein-tyrosine-kinase-candidates-as-promising-therapeutic-targets-for-pancreatic-cancer-risk-stratification
#3
JOURNAL ARTICLE
Huan Zhang, Paul Winter, Thomas Wartmann, Luca Simioni, Sara Al-Madhi, Aris Perrakis, Roland S Croner, Wenjie Shi, Quan Yu, Ulf D Kahlert
Background: Uncover the pivotal link between lymphocyte-specific protein tyrosine kinase (Lck)-related genes and clinical risk stratification in pancreatic cancer. Methods: This study identifies shared genes between differentially expressed genes (DEGs) and Lck-related genes in pancreatic cancer using a methodological framework rooted in The Cancer Genome Atlas database. Feature gene selection is accomplished and a signature model is constructed. Statistical significant clinical endpoints such as overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI) were defined...
June 5, 2024: Cancer Biotherapy & Radiopharmaceuticals
https://read.qxmd.com/read/38837231/identification-of-ppy-lineage-cells-as-a-novel-origin-of-pancreatic-ductal-adenocarcinoma
#4
JOURNAL ARTICLE
Ofejiro Blessing Pereye, Yuko Nakagawa, Takashi Sato, Ayako Fukunaka, Shuhei Aoyama, Yuya Nishida, Wakana Mizutani, Nanami Kobayashi, Yohei Morishita, Tetsunari Oyama, Reika Kawabata-Iwakawa, Hirotaka Watada, Hiroki Mizukami, Akihisa Fukuda, Yoshio Fujitani
The Ppy gene encodes pancreatic polypeptide (PP) secreted by PP- or γ-cells, which are a subtype of endocrine cells localised mainly in the islet periphery. For a detailed characterisation of PP cells, we aimed to establish PP cell lines. To this end, we generated a mouse model harbouring the SV40 large T antigen (TAg) in the Rosa26 locus, which is expressed upon Ppy-promoter-mediated Cre-loxP recombination. Whereas Insulin1-CreERT-mediated TAg expression in beta cells resulted in insulinoma, surprisingly, Ppy-Cre-mediated TAg expression resulted in the malignant transformation of Ppy-lineage cells...
June 4, 2024: Journal of Pathology
https://read.qxmd.com/read/38836973/a-case-of-brca1-mutated-giant-pancreatic-acinar-cell-carcinoma-successfully-treated-with-modified-folfirinox-therapy-and-radical-resection
#5
JOURNAL ARTICLE
Toru Watanabe, Yasuhiro Nagaoka, Nana Kimura, Mina Fukasawa, Yoshihiro Shirai, Katsuhisa Hirano, Kazuto Shibuya, Isaku Yoshioka, Takeru Hamashima, Tsutomu Fujii
Pancreatic acinar cell carcinoma (PACC) is a rare type of pancreatic cancer; further, its pathogenesis and treatment strategies remain unclear. We report the case of a 70-year-old man who presented with a chief complaint of abdominal distention. Computed tomography scans revealed a large lobulated mass (tumor diameter: 150 mm) in the pancreatic body tail, which was diagnosed as a PACC through endoscopic ultrasonography fine needle aspiration. The other imaging modalities did not reveal distant metastases, and the tumor was classified as resectable...
June 5, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38836800/preoperative-low-skeletal-muscle-mass-index-assessed-using-l3-ct-as-a-prognostic-marker-of-clinical-outcomes-in-pancreatic-cancer-patients-undergoing-surgery-a-systematic-review-and-meta-analysis
#6
JOURNAL ARTICLE
Pauline Raoul, Marco Cintoni, Alessandro Coppola, Sergio Alfieri, Giampaolo Tortora, Antonio Gasbarrini, Maria Cristina Mele, Emanuele Rinninella
BACKGROUND: Reduction in muscle mass can be routinely quantified using computed tomography (CT) of the third lumbar vertebra (L3) during a curative pancreatic cancer (PC) course. This systematic review and meta-analysis aimed to assess the association between preoperative low skeletal muscle index (SMI) measured by L3 CT and postoperative clinical outcomes in PC resectable patients. METHODS: Three electronic databases (PubMed, Web of Science, and Scopus) were searched for articles published through May 2023...
December 11, 2023: International Journal of Surgery
https://read.qxmd.com/read/38836387/a-chiral-trimethyl-lock-based-on-the-vicinal-disubstituent-effect-prolonged-release-of-camptothecin-into-cancer-cells
#7
JOURNAL ARTICLE
Silvia Venturi, Ferdinando Chiaradonna, Francesco G Gatti, Barbara La Ferla, Roberta Palorini, Barbara Zerbato
Synthesis and in vitro testing of a prodrug designed for the controlled delivery of the anticancer drug camptothecin within pancreatic cancer cells are reported. Our study reveals a non-conventional pharmacokinetic release characterized by an exponential pattern before reaching the half-life ( t 1/2 ) and a linear pattern thereafter. The release mechanism was triggered either by hydrolytic enzymes and/or by the acid microenvironment of cancer cells.
June 5, 2024: Chemical Communications: Chem Comm
https://read.qxmd.com/read/38835644/diabetes-and-cancer-a-twisted-bond
#8
REVIEW
Mihai Cosmin Stan, Doru Paul
This paper presents an overview of the interconnection between various factors related to both cancer and type 2 diabetes mellitus (T2DM). Hyperglycemia, hyperinsulinemia, chronic inflammation, and obesity are involved in the development and progression of both diseases but, strong evidence for a direct causal relationship between diabetes and cancer, is lacking. Several studies described a relationship between hyperglycemia and cancer at the cellular, tissular and organismic levels but at the same time recent Mendelian randomization studies proved a significant causal relationship only between hyperglycemia and breast cancer...
2024: Oncology Reviews
https://read.qxmd.com/read/38835083/blood-flow-restriction-exercise-in-the-perioperative-setting-to-prevent-loss-of-muscle-mass-in-patients-with-pancreatic-biliary-tract-and-liver-cancer-study-protocol-for-the-prev-ex-randomized-controlled-trial
#9
JOURNAL ARTICLE
Poorna Anandavadivelan, Daniele Cardinale, Rune Blomhoff, Berit Sunde, Kristoffer Lassen, Dyre Kleive, Christian Sturesson, Stefan Gilg, Truls Raastad, Sara Mijwel
BACKGROUND: Patients diagnosed with pancreatic, biliary tract, and liver cancer often suffer from a progressive loss of muscle mass. Given the considerable functional impairments in these patients, high musculoskeletal weight loads may not be well tolerated by all individuals. The use of blood-flow restricted resistance training (BFR-T) which only requires low training loads may allow for a faster recovery of muscle due to avoidance of high levels of mechanical muscle stress associated with high-load resistance exercise...
June 4, 2024: Trials
https://read.qxmd.com/read/38835067/associations-of-body-composition-parameters-with-postoperative-outcome-and-perineural-tumour-invasion-after-oncological-pancreatic-resection
#10
JOURNAL ARTICLE
Tara C Mueller, Martin Henselmann, Stefan Reischl, Carsten Jaeger, Charlotte Trefzer, Ihsan Ekin Demir, Helmut Friess, Marc E Martignoni
BACKGROUND: Pancreatic cancer is often accompanied by wasting conditions. While surgery is the primary curative approach, it poses a substantial risk of postoperative complications, hindering subsequent treatments. Therefore, identifying patients at high risk for complications and optimizing their perioperative general condition is crucial. Sarcopenia and other body composition abnormalities have shown to adversely affect surgical and oncological outcomes in various cancer patients. As most pancreatic tumours are located close to the neuronal control centre for the digestive tract, it is possible that neural infiltration in this area deranges bowel functions and contributes to malabsorption and malnutrition and ultimately worsen sarcopenia and weight loss...
June 4, 2024: BMC Surgery
https://read.qxmd.com/read/38835055/current-and-future-immunotherapeutic-approaches-in-pancreatic-cancer-treatment
#11
REVIEW
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, Ali-Akbar Delbandi
Pancreatic cancer is a major cause of cancer-related death, but despondently, the outlook and prognosis for this resistant type of tumor have remained grim for a long time. Currently, it is extremely challenging to prevent or detect it early enough for effective treatment because patients rarely exhibit symptoms and there are no reliable indicators for detection. Most patients have advanced or spreading cancer that is difficult to treat, and treatments like chemotherapy and radiotherapy can only slightly prolong their life by a few months...
June 4, 2024: Journal of Hematology & Oncology
https://read.qxmd.com/read/38834827/a-suspected-case-of-serum-igg4-negative-type-1-autoimmune-pancreatitis-detected-due-to-localized-pancreatic-duct-narrowing-a-case-report
#12
JOURNAL ARTICLE
Karen Kimura, Kazuya Koizumi, Sakue Masuda, Makomo Makazu, Jun Kubota, Shinichi Teshima
A 50-year-old woman was referred to our hospital with elevated serum amylase levels. Physical examination revealed no jaundice or abdominal tenderness. Serum IgG4 was negative. Computed tomography revealed a localized pancreatic duct narrowing in the pancreatic head, with caudal pancreatic duct dilation and an intraductal papillary mucinous neoplasm. Pancreatic enlargement was not observed. Endoscopic ultrasonography (EUS) showed a small hypoechoic mass. Although EUS-guided, fine-needle aspiration was performed, no diagnosis was established...
June 4, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38834297/dyrk1b-blockade-promotes-tumoricidal-macrophage-activity-in-pancreatic-cancer
#13
JOURNAL ARTICLE
Anna Brichkina, Miriam Ems, Roman Suezov, Rajeev Singh, Veronika Lutz, Felix S R Picard, Andrea Nist, Thorsten Stiewe, Johannes Graumann, Michael Daude, Wibke E Diederich, Florian Finkernagel, Ho-Ryun Chung, Detlef K Bartsch, Katrin Roth, Corinna Keber, Carsten Denkert, Magdalena Huber, Thomas M Gress, Matthias Lauth
OBJECTIVE: Highly malignant pancreatic ductal adenocarcinoma (PDAC) is characterised by an abundant immunosuppressive and fibrotic tumour microenvironment (TME). Future therapeutic attempts will therefore demand the targeting of tumours and stromal compartments in order to be effective. Here we investigate whether dual specificity and tyrosine phosphorylation-regulated kinase 1B (DYRK1B) fulfil these criteria and represent a promising anticancer target in PDAC. DESIGN: We used transplantation and autochthonous mouse models of PDAC with either genetic Dyrk1b loss or pharmacological DYRK1B inhibition, respectively...
June 4, 2024: Gut
https://read.qxmd.com/read/38834088/small-steps-can-lead-to-substantial-breakthroughs-moving-the-therapeutic-needle-forward-in-pancreatic-cancer
#14
JOURNAL ARTICLE
Priyadarshini Pathak, Colin Weekes, Jennifer Y Wo
No abstract text is available yet for this article.
May 31, 2024: Lancet Oncology
https://read.qxmd.com/read/38833646/pretargeted-radioimmunotherapy-with-the-novel-anti-oxmif-hsg-bispecific-antibody-on105-results-in-significant-tumor-regression-in-murine-models-of-cancer
#15
JOURNAL ARTICLE
Alejandro A Puchol Tarazona, Alexander Schinagl, Irina Mirkina, Gregor Rossmueller, Randolf J Kerschbaumer, Friedmund Bachmann, Michael Thiele
Radioimmunotherapy (RIT) uses mAbs to deliver radionuclides to cancer cells or the tumor microenvironment and has shown promise in treating localized and diffuse tumors. While RIT agents have gained FDA/EMA approval for certain hematological malignancies, effectiveness of RIT in treating solid tumors remains limited. Here we present PreTarg-it®, a novel approach for pretargeted radioimmunotherapy, providing optimized delivery of payloads in a two-step regimen. The effectiveness of PreTarg-it® is demonstrated by a powerful combination of ON105, a novel bispecific antibody against both oxMIF and the histamine-succinyl-glycyl (HSG) hapten, as the first component and the radioactively labeled DOTA-di-HSG peptide as the second component in murine models of cancer...
June 5, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38833603/retrospective-study-of-germline-variants-in-patients-with-hereditary-melanoma-study-criteria-in-a-real-clinical-practice-setting
#16
JOURNAL ARTICLE
Jose Maria Villa-Gonzalez, Sergio Carrera Revilla, Lara Lombardero Gutiérrez, Jesús Gardeazabal García
INTRODUCTION: Five to twelve percent of melanomas show aggregation of melanomas or other related tumors within the same family or individual. Genes such as CDKN2A, or BAP1, among others, have been involved in this condition. MATERIAL AND METHODS: Retrospective descriptive study that includes patients from Cruces University Hospital (2016-2023) who met any of the following criteria: presence of two or more melanomas (1), or a melanoma and a pancreatic cancer (2) in the same individual; presence of a melanoma in an individual and one or more first- or second-degree relatives with melanoma or pancreatic cancer (3); first- or second-degree relationship with an individual with a known deleterious variant in genes related to melanoma predisposition (4); or incidental discovery of deleterious variants in genes related to predisposition to melanoma, within hereditary cancer panels carried out for reasons other than melanoma (5)...
June 4, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38832050/analysis-of-the-direct-economic-impact-of-smoking-related-hospitalizations-in-italy
#17
JOURNAL ARTICLE
Irene Possenti, Marco Scala, Magda Rognoni, Alessandra Lugo, Maria S Cattaruzza, Sabrina Molinaro, Anna Odone, Luc J M Smits, Vincenzo Zagà, Silvano Gallus, Luca Cavalieri d'Oro
INTRODUCTION: Tobacco-related diseases have a substantial economic impact in terms of medical expenses, loss of productivity, and premature death. Tobacco use is estimated to be responsible for more than 90000 deaths each year in Italy. We aimed to evaluate the annual direct economic impact on the National Health System of hospitalizations attributable to tobacco smoking in Italy. METHODS: We analyzed data from all the hospitalizations of patients aged ≥30 years that occurred in Italy for 12 selected tobacco-related diseases, during 2018...
2024: Tobacco Induced Diseases
https://read.qxmd.com/read/38831754/treatment-planning-for-mr-guided-sbrt-of-pancreatic-tumors-on-a-1-5-t-mr-linac-a-global-consensus-protocol
#18
JOURNAL ARTICLE
Guus Grimbergen, Hidde Eijkelenkamp, Louk M W Snoeren, Rana Bahij, Uffe Bernchou, Erik van der Bijl, Hanne D Heerkens, Shawn Binda, Sylvia S W Ng, Christelle Bouchart, Zelda Paquier, Kerryn Brown, Richard Khor, Robert Chuter, Linnéa Freear, Alex Dunlop, Robert Adam Mitchell, Beth A Erickson, William A Hall, Paola Godoy Scripes, Neelam Tyagi, Jeremiah de Leon, Charles Tran, Seungjong Oh, Paul Renz, Andrea Shessel, Edward Taylor, Martijn P W Intven, Gert J Meijer
BACKGROUND AND PURPOSE: Treatment planning for MR-guided stereotactic body radiotherapy (SBRT) for pancreatic tumors can be challenging, leading to a wide variation of protocols and practices. This study aimed to harmonize treatment planning by developing a consensus planning protocol for MR-guided pancreas SBRT on a 1.5 T MR-Linac. MATERIALS AND METHODS: A consortium was founded of thirteen centers that treat pancreatic tumors on a 1.5 T MR-Linac. A phased planning exercise was conducted in which centers iteratively created treatment plans for two cases of pancreatic cancer...
July 2024: Clinical and Translational Radiation Oncology
https://read.qxmd.com/read/38831749/a-hypoxia-epigenetics-axis-drives-emt-in-pancreatic-cancer
#19
JOURNAL ARTICLE
Matthias Wirth, Günter Schneider
Epithelial-to-mesenchymal transition (EMT) is a classical cellular plasticity process induced by various cell-intrinsic and -extrinsic triggers. Although prominent factors, such as TGFβ, mediate EMT via well-characterized pathways, alternative avenues are less well understood. Transcriptomic subtyping of pancreatic ductal adenocarcinoma (PDAC) has demonstrated that basal-like PDACs enrich a mesenchymal-like expression program, emphasizing the relevance of EMT in the disease. In this issue of Cancer Research, Brown and colleagues demonstrate the tight connection of EMT to hypoxia...
June 4, 2024: Cancer Research
https://read.qxmd.com/read/38831540/exploring-the-molecular-therapeutic-mechanisms-of-gemcitabine-through-quantitative-proteomics
#20
JOURNAL ARTICLE
Yue Jiang, Xuelian Ren, Jing Zhao, Guobin Liu, Fangfang Liu, Xinlong Guo, Ming Hao, Hong Liu, Kun Liu, He Huang
Gemcitabine (GEM) is widely employed in the treatment of various cancers, including pancreatic cancer. Despite their clinical success, challenges related to GEM resistance and toxicity persist. Therefore, a deeper understanding of its intracellular mechanisms and potential targets is urgently needed. In this study, through mass spectrometry analysis in data-dependent acquisition mode, we carried out quantitative proteomics (three independent replications) and thermal proteome profiling (TPP, two independent replications) on MIA PaCa-2 cells to explore the effects of GEM...
June 3, 2024: Journal of Proteome Research
keyword
keyword
92518
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.